Literature DB >> 30236533

Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise.

Laura Micheli1, Manuela Ceccarelli2, Giorgio D'Andrea3, Felice Tirone4.   

Abstract

Of wide interest for health is the relation existing between depression, a very common psychological illness, accompanied by anxiety and reduced ability to concentrate, and adult neurogenesis. We will focus on two neurogenic stimuli, fluoxetine and physical exercise, both endowed with the ability to activate adult neurogenesis in the dentate gyrus of the hippocampus, known to be required for learning and memory, and both able to counteract depression. Fluoxetine belongs to the class of selective serotonin reuptake inhibitor (SSRI) antidepressants, which represent the most used pharmacological therapy; physical exercise has also been shown to effectively counteract depression symptoms in rodents as well as in humans. While there is evidence that the antidepressant effect of fluoxetine requires its pro-neurogenic action, exerted by promoting proliferation, differentiation and survival of progenitor cells of the hippocampus, on the other hand fluoxetine exerts also neurogenesis-independent antidepressant effects by influencing the plasticity of the new neurons generated. Similarly, the antidepressant action of running also correlates with an increase of hippocampal neurogenesis and plasticity, although the gene pathways involved are only partially coincident with those of fluoxetine, such as those involved in serotonin metabolism and synapse formation. We further discuss how extra-neurogenic actions are also suggested by the fact that, unlike running, fluoxetine is unable to stimulate neurogenesis during aging, but still displays antidepressant effects. Moreover, in specific conditions, fluoxetine or running activate not only progenitor but also stem cells, which normally are not stimulated; this fact reveals how stem cells have a long-term, hidden ability to self-renew and, more generally, that neurogenesis is subject to complex controls that may play a role in depression, such as the type of neurogenic stimulus or the state of the local niche. Finally, we discuss how fluoxetine or running are effective in counteracting depression originated from stress or neurodegenerative diseases.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult neurogenesis; Depression; Fluoxetine; Neural stem cells; Neurogenic stimuli; Running

Mesh:

Substances:

Year:  2018        PMID: 30236533     DOI: 10.1016/j.brainresbull.2018.09.002

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  44 in total

1.  Creative, Person-Centered Narrative Psychopharmacotherapy of Depression.

Authors:  Miro Jakovljevic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Adenosine protects D-galactose induced alterations in rat model of aging via attenuating neurochemical profile and redox status.

Authors:  Noreen Samad; Arooj Nasir; Muhammad Habib Ur Rehman; Sheraz Ahmed Bhatti; Imran Imran
Journal:  Metab Brain Dis       Date:  2022-07-23       Impact factor: 3.655

3.  Impaired hippocampal neurogenesis in vitro is modulated by dietary-related endogenous factors and associated with depression in a longitudinal ageing cohort study.

Authors:  Andrea Du Preez; Sophie Lefèvre-Arbogast; Raúl González-Domínguez; Vikki Houghton; Chiara de Lucia; Dorrain Y Low; Catherine Helmer; Catherine Féart; Cécile Delcourt; Cécile Proust-Lima; Mercè Pallàs; Alex Sánchez-Pla; Mireia Urpi-Sardà; Silvie R Ruigrok; Barbara Altendorfer; Ludwig Aigner; Paul J Lucassen; Aniko Korosi; Claudine Manach; Cristina Andres-Lacueva; Cécilia Samieri; Sandrine Thuret
Journal:  Mol Psychiatry       Date:  2022-07-07       Impact factor: 13.437

Review 4.  Drugs and Endogenous Factors as Protagonists in Neurogenic Stimulation.

Authors:  Raphaela A Chiareli; Bruno L Marques; Gustavo A de Carvalho; Raysa T V de Souza; Pedro H G Santana; Helton C Santiago; Mauro C X Pinto; Alexander Birbrair; Ricardo C Parreira; Henning Ulrich; Rodrigo R Resende
Journal:  Stem Cell Rev Rep       Date:  2022-08-12       Impact factor: 6.692

5.  Antidepressant-like activity of oroxylin A in mice models of depression: A behavioral and neurobiological characterization.

Authors:  Zhong-Hua Wu; Hua Fan; Shang-Yan Gao; Yan-Fei Jin; Bo Jiang; Jian Shen
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

6.  Effect of fluoxetine on the testes of adult albino rats and the possible protective role of curcumin.

Authors:  Basma Fathi Elsedawi; Youssef Hussein; Mohamed Ahmed Sabry; Joseph Amin Aziz
Journal:  Anat Sci Int       Date:  2020-10-14       Impact factor: 1.741

Review 7.  Neuromodulation-Based Stem Cell Therapy in Brain Repair: Recent Advances and Future Perspectives.

Authors:  Ti-Fei Yuan; Yi Dong; Li Zhang; Jieyu Qi; Chun Yao; Yongjun Wang; Renjie Chai; Yan Liu; Kwok-Fai So
Journal:  Neurosci Bull       Date:  2021-04-19       Impact factor: 5.203

8.  β-arrestin 2 is essential for fluoxetine-mediated promotion of hippocampal neurogenesis in a mouse model of depression.

Authors:  Chen-Xin Li; Ying Zheng; Hong Zhu; Cheng-Wu Li; Zhang He; Cong Wang; Jian-Hua Ding; Gang Hu; Ming Lu
Journal:  Acta Pharmacol Sin       Date:  2021-02-01       Impact factor: 6.150

9.  Increasing Adult Hippocampal Neurogenesis Promotes Resilience in a Mouse Model of Depression.

Authors:  Barbara Planchez; Natalia Lagunas; Anne-Marie Le Guisquet; Marc Legrand; Alexandre Surget; René Hen; Catherine Belzung
Journal:  Cells       Date:  2021-04-21       Impact factor: 7.666

10.  Altered Dentate Gyrus Microstructure in Individuals at High Familial Risk for Depression Predicts Future Symptoms.

Authors:  Milenna T van Dijk; Jiook Cha; David Semanek; Natalie Aw; Marc J Gameroff; Eyal Abraham; Priya J Wickramaratne; Myrna M Weissman; Jonathan Posner; Ardesheer Talati
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.